Tacrolimus treatment for relapsing-remitting chronic inflammatory demyelinating polyradiculoneuropathy: Two case reports
- PMID: 35211613
- PMCID: PMC8855276
- DOI: 10.12998/wjcc.v10.i5.1709
Tacrolimus treatment for relapsing-remitting chronic inflammatory demyelinating polyradiculoneuropathy: Two case reports
Abstract
Background: This study describes the efficacy of a tacrolimus treatment regimen used to treat two patients with relapsing-remitting chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Case summary: Two patients (17-year-old female and 27-year-old male) were enrolled in the current study and were followed up for 12 mo. The first patient was administered tacrolimus (2 mg/d) for 12 mo and prednisolone (40 mg/d) for six months. The second patient was administered tacrolimus (3 mg/d) for six months. Both patients were followed up for 12 mo and the degree of recurrent weakness or normalized motor function was monitored. In addition, nerve conduction studies and tacrolimus levels were recorded. Following tacrolimus treatment, both patients showed marked improvement in clinical outcomes. In the first patient, prednisolone treatment was successfully withdrawn after six months. Sensory as well as motor nerve conduction velocities showed evident recovery following treatment. However, conduction velocities did not completely return to normal, suggesting that electrophysiological recovery can be slower than clinical recovery.
Conclusion: Neither patient exhibited any adverse effects due to the tacrolimus therapy. Therefore, tacrolimus can be effective for the treatment of patients with steroid-resistant CIDP.
Keywords: Case report; Chronic inflammatory demyelinating polyradiculoneuropathy; Prednisolone; Relapsing-remitting; Tacrolimus; Treatment.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Exacerbation of chronic inflammatory demyelinating polyradiculoneuropathy during interferonbeta-1b therapy in a patient with childhood-onset multiple sclerosis.Intern Med. 2005 Jan;44(1):68-72. doi: 10.2169/internalmedicine.44.68. Intern Med. 2005. PMID: 15704667
-
Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?Neurol India. 2011 Sep-Oct;59(5):664-8. doi: 10.4103/0028-3886.86537. Neurol India. 2011. PMID: 22019647
-
Cyclosporine in chronic inflammatory demyelinating polyradiculoneuropathy.Pediatr Neurol. 2005 Nov;33(5):368-72. doi: 10.1016/j.pediatrneurol.2005.05.015. Pediatr Neurol. 2005. PMID: 16243226
-
History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.Mayo Clin Proc. 2018 Jun;93(6):777-793. doi: 10.1016/j.mayocp.2018.03.026. Mayo Clin Proc. 2018. PMID: 29866282 Review.
-
Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.Eur J Paediatr Neurol. 2012 Jul;16(4):315-31. doi: 10.1016/j.ejpn.2011.12.003. Epub 2012 Jan 4. Eur J Paediatr Neurol. 2012. PMID: 22225859 Review.
Cited by
-
Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins.Neuropsychiatr Dis Treat. 2022 Jun 16;18:1207-1217. doi: 10.2147/NDT.S361461. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 35734550 Free PMC article.
References
-
- Köller H, Kieseier BC, Jander S, Hartung HP. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med. 2005;352:1343–1356. - PubMed
-
- Vallat JM, Sommer C, Magy L. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol. 2010;9:402–412. - PubMed
-
- Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, Léger JM, Nobile-Orazio E, Pollard J, Sommer C, van Doorn PA, van Schaik IN European Federation of Neurological Societies; Peripheral Nerve Society. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol. 2010;17:356–363. - PubMed
-
- Dyck PJB, Tracy JA. History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Mayo Clin Proc. 2018;93:777–793. - PubMed
Publication types
LinkOut - more resources
Full Text Sources